Mednax
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $468,844 | $458,359 | $502,364 | $511,158 |
Gross Profit | 124,728 | 102,642 | 121,653 | 116,821 |
EBITDA | 69,412 | 42,576 | 49,911 | 41,615 |
EBIT | 64,099 | 37,244 | 43,038 | 35,361 |
Net Income | 39,260 | 20,737 | 30,480 | 19,441 |
Net Change In Cash | 468,844 | 458,359 | 502,364 | 511,158 |
Free Cash Flow | 132,652 | -120,781 | 129,570 | 94,430 |
Cash | 224,732 | 98,978 | 229,940 | 103,831 |
Basic Shares | 86,854 | 85,810 | 85,866 | 84,523 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,012,919 | $1,994,640 | $1,972,021 | $1,911,191 |
Gross Profit | 454,344 | 421,565 | 467,033 | 513,242 |
EBITDA | -28,372 | 29,887 | 235,636 | 249,885 |
EBIT | -60,598 | -6,284 | 200,000 | 217,738 |
Net Income | -99,069 | -60,408 | 66,335 | 130,964 |
Net Change In Cash | 2,012,919 | 1,994,640 | 1,972,021 | 1,911,191 |
Cost of Revenue | -377,567 | -736,452 | ||
Free Cash Flow | 184,551 | 103,997 | 137,233 | 44,488 |
Cash | 229,940 | 73,258 | 9,824 | 387,391 |
Basic Shares | 83,330 | 82,201 | 84,121 | 85,828 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.53 |
2025-03-31 | $0.24 |
2024-12-31 | $0.51 |
2024-09-30 | $0.44 |
